Repository logo
 

The evolution of two transmissible cancers in Tasmanian devils

Accepted version
Peer-reviewed

Loading...
Thumbnail Image

Change log

Abstract

Tasmanian devils have spawned two transmissible cancer lineages, named devil facial tumour 1 (DFT1) and devil facial tumour 2 (DFT2). We investigated the genetic diversity and evolution of these clones by analysing 78 DFT1 and 41 DFT2 genomes relative to a newly assembled chromosome-level reference. Time-resolved phylogenetic trees reveal that DFT1 first emerged in 1986 (1982-1989), and DFT2 in 2011 (2009-2012). Subclone analysis documents transmission of heterogeneous cell populations. DFT2 has faster mutation rates than DFT1 across all variant classes, including substitutions, indels, rearrangements, transposable element insertions and copy number alterations, and we identify a hypermutated DFT1 lineage with defective DNA mismatch repair. Several loci show plausible evidence of positive selection in DFT1 or DFT2, including loss of chromosome Y and inactivation of MGA, but none are common to both cancers. This study reveals the parallel long-term evolution of two transmissible cancers inhabiting a common niche in Tasmanian devils.

Description

Journal Title

Science

Conference Name

Journal ISSN

0036-8075
1095-9203

Volume Title

Publisher

American Association for the Advancement of Science

Rights and licensing

Except where otherwised noted, this item's license is described as All Rights Reserved
Sponsorship
Wellcome Trust (102942/Z/13/Z)
Wellcome Trust (222551/Z/21/Z)
This work was supported by grants from Wellcome (102942/Z/13 and 222551/Z/21), as well as Eric Guiler Tasmanian Devil Research Grants from the University of Tasmania Foundation. F.J.M. and K.B. were funded by Wellcome grants WT108749/Z/15/Z and WT222155/Z/20/Z and an Eric Guiler Tasmanian Devil Research Grant from the University of Tasmania Foundation. Additional field work was supported by grants from the Australian Research Council (LP0561120, LP0989613, DP110102656 – M.J.; DE170101116, LP170101105 – R.H.), the US National Science Foundation (DEB-1316549 – M.J. and E.P.M.), and the US National Institutes of Health (1R01GM126563-01 – M.J.). R.H. is supported by the MAVA Foundation. M.R.Stammnitz was supported by a Gates Cambridge Trust Scholarship.

Relationships

Is derived from: